| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.994 | Human |
| nucleotide catabolic process | GO:0009166 | 217 | 0.992 | Human |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.991 | Human |
| nucleotide metabolic process | GO:0009117 | 332 | 0.984 | Human |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.982 | Human |
| positive regulation of protein export from nucleus | GO:0046827 | 4 | 0.977 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.971 | |
| organelle localization | GO:0051640 | 179 | 0.965 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.962 | Human |
| nucleoside catabolic process | GO:0009164 | 206 | 0.960 | Human |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.958 | Human |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.957 | Human |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.954 | Human |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.946 | Human |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.938 | Human |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.935 | Human |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.931 | Human |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.915 | Human |
| thermosensory behavior | GO:0040040 | 1 | 0.914 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.907 | Human |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.905 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.904 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.903 | Human |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.903 | Human |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.891 | Human |
| intracellular protein transport | GO:0006886 | 204 | 0.890 | Human |
| gtp catabolic process | GO:0006184 | 143 | 0.880 | Human |
| nucleoside metabolic process | GO:0009116 | 246 | 0.878 | Human |
| keratinocyte development | GO:0003334 | 10 | 0.870 | |
| oocyte axis specification | GO:0007309 | 2 | 0.864 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.857 | Human |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.841 | Human |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.840 | Human |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.835 | Human |
| heterocycle catabolic process | GO:0046700 | 280 | 0.830 | Human |
| mitochondrion distribution | GO:0048311 | 4 | 0.830 | Human Fly |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.819 | |
| protein targeting | GO:0006605 | 143 | 0.818 | Human |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.817 | Human |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.802 | |
| nucleus localization | GO:0051647 | 20 | 0.801 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.798 | Human |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.794 | Human |
| regulation of mitochondrial fission | GO:0090140 | 3 | 0.785 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.785 | Fly |
| spindle localization | GO:0051653 | 22 | 0.785 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.781 | Human |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.780 | Human |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.778 | Human |
| negative regulation of ubiquitin protein transferase activity | GO:0051444 | 3 | 0.773 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.772 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.771 | |
| regulation of ubiquitin protein ligase activity involved in mitotic cell cycle | GO:0051439 | 1 | 0.764 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.758 | Human |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.757 | Human |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.752 | Human |
| regulation of exit from mitosis | GO:0007096 | 1 | 0.747 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.738 | Human |
| membrane organization | GO:0061024 | 245 | 0.729 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.727 | Human |
| oocyte construction | GO:0007308 | 2 | 0.720 | |
| dephosphorylation | GO:0016311 | 129 | 0.719 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.705 | Human |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.702 | |
| microtubule based process | GO:0007017 | 236 | 0.696 | Fly |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.695 | Human |
| positive regulation of protein transport | GO:0051222 | 93 | 0.693 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.693 | Human |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.688 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.682 | Human |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.682 | Fly |
| gtp metabolic process | GO:0046039 | 144 | 0.670 | Human |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.669 | |
| negative regulation of ligase activity | GO:0051352 | 3 | 0.669 | |
| cytokinesis | GO:0000910 | 17 | 0.659 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.655 | |
| protein polymerization | GO:0051258 | 57 | 0.642 | |
| regulation of epidermal cell division | GO:0010482 | 3 | 0.641 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.641 | |
| endocytosis | GO:0006897 | 168 | 0.628 | Human Fly |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.614 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.603 | Human |
| regulation of ligase activity | GO:0051340 | 10 | 0.602 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.591 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.559 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.557 | Human |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.549 | Human |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.548 | Human |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.544 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.543 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.540 | Human |
| lamellipodium organization | GO:0097581 | 29 | 0.536 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.532 | |
| regulation of lamellipodium assembly | GO:0010591 | 3 | 0.532 | |
| regulation of protein stability | GO:0031647 | 52 | 0.530 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.518 | Human |
| organism emergence from protective structure | GO:0071684 | 4 | 0.518 | |
| vacuole organization | GO:0007033 | 38 | 0.513 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.512 | Human |
| chromosome segregation | GO:0007059 | 48 | 0.510 | |
| atp metabolic process | GO:0046034 | 75 | 0.500 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.495 | |
| cognition | GO:0050890 | 149 | 0.491 | |
| protein export from nucleus | GO:0006611 | 20 | 0.490 | |
| synaptic transmission | GO:0007268 | 329 | 0.485 | |
| forebrain development | GO:0030900 | 302 | 0.485 | Human |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.483 | Human |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.479 | |
| establishment of mitotic spindle localization | GO:0040001 | 12 | 0.477 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.475 | |
| establishment of spindle localization | GO:0051293 | 19 | 0.471 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.469 | Human |
| mitochondrion organization | GO:0007005 | 134 | 0.462 | Human Fly |
| cell division | GO:0051301 | 120 | 0.454 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.454 | Human |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.448 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.440 | Human |
| cell adhesion | GO:0007155 | 329 | 0.430 | |
| regulation of actin filament polymerization | GO:0030833 | 38 | 0.417 | |
| regulation of protein transport | GO:0051223 | 163 | 0.413 | Human |
| regulation of ubiquitin protein transferase activity | GO:0051438 | 7 | 0.409 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.404 | |
| cellular glucan metabolic process | GO:0006073 | 32 | 0.396 | |
| regulation of mitochondrion organization | GO:0010821 | 27 | 0.393 | Human |
| actin filament organization | GO:0007015 | 113 | 0.390 | |
| positive regulation of intracellular protein transport | GO:0090316 | 42 | 0.390 | |
| aggresome assembly | GO:0070842 | 2 | 0.388 | |
| negative regulation of actin filament depolymerization | GO:0030835 | 9 | 0.386 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.386 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.377 | Human |
| muscle cell differentiation | GO:0042692 | 261 | 0.359 | |
| positive regulation of mitochondrion organization | GO:0010822 | 17 | 0.355 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.354 | Human |
| glucan metabolic process | GO:0044042 | 32 | 0.350 | |
| positive regulation of rac gtpase activity | GO:0032855 | 14 | 0.348 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.346 | |
| positive regulation of nucleocytoplasmic transport | GO:0046824 | 30 | 0.341 | |
| regulation of protein export from nucleus | GO:0046825 | 11 | 0.338 | |
| epidermal cell division | GO:0010481 | 3 | 0.321 | |
| actin filament polymerization | GO:0030041 | 44 | 0.318 | |
| developmental maturation | GO:0021700 | 193 | 0.317 | Human Fly |
| zygote asymmetric cell division | GO:0010070 | 2 | 0.316 | |
| organelle fission | GO:0048285 | 170 | 0.316 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.315 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.314 | Human Fly |
| regulation of intracellular transport | GO:0032386 | 159 | 0.305 | Human |
| inclusion body assembly | GO:0070841 | 3 | 0.303 | |
| mapk cascade | GO:0000165 | 281 | 0.298 | Human |
| hatching | GO:0035188 | 4 | 0.296 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.293 | |
| negative regulation of keratinocyte proliferation | GO:0010839 | 7 | 0.288 | |
| negative regulation of dephosphorylation | GO:0035305 | 9 | 0.287 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.283 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.282 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.277 | |
| epithelial cell development | GO:0002064 | 159 | 0.276 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.276 | Human |
| telencephalon development | GO:0021537 | 186 | 0.275 | Human |
| neuron migration | GO:0001764 | 122 | 0.275 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.274 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.274 | |
| muscle cell development | GO:0055001 | 133 | 0.271 | |
| intracellular distribution of mitochondria | GO:0048312 | 1 | 0.268 | Human Fly |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.266 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.263 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.258 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.255 | Human |
| oxidation reduction process | GO:0055114 | 342 | 0.254 | Human |
| regulation of substrate adhesion dependent cell spreading | GO:1900024 | 12 | 0.253 | |
| polysaccharide metabolic process | GO:0005976 | 39 | 0.249 | |
| regionalization | GO:0003002 | 337 | 0.247 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.236 | Human |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.234 | |
| establishment of spindle orientation | GO:0051294 | 15 | 0.234 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.230 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.229 | Human |
| membrane fusion | GO:0061025 | 38 | 0.229 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.229 | Human |
| protein localization to organelle | GO:0033365 | 185 | 0.228 | Human |
| cellular polysaccharide metabolic process | GO:0044264 | 38 | 0.222 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.220 | |
| protein depolymerization | GO:0051261 | 34 | 0.220 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.220 | |
| regulation of actin filament length | GO:0030832 | 45 | 0.218 | |
| regulation of protein ubiquitination | GO:0031396 | 52 | 0.215 | Human |
| pole plasm assembly | GO:0007315 | 2 | 0.213 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.211 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.209 | Human |
| regulation of cell division | GO:0051302 | 76 | 0.207 | |
| positive regulation of cytoplasmic transport | GO:1903651 | 40 | 0.207 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.206 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.206 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.198 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.195 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.192 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.191 | |
| glycogen metabolic process | GO:0005977 | 32 | 0.190 | |
| nuclear transport | GO:0051169 | 139 | 0.189 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.186 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.184 | Human |
| regulation of cell projection assembly | GO:0060491 | 38 | 0.183 | |
| single fertilization | GO:0007338 | 82 | 0.181 | |
| microtubule based movement | GO:0007018 | 84 | 0.181 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.180 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.180 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.180 | |
| actin filament depolymerization | GO:0030042 | 15 | 0.179 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.177 | |
| positive regulation of lamellipodium organization | GO:1902745 | 3 | 0.175 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.174 | |
| regulation of cyclin dependent protein serine threonine kinase activity | GO:0000079 | 16 | 0.170 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.169 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.168 | |
| positive regulation of release of cytochrome c from mitochondria | GO:0090200 | 5 | 0.166 | |
| positive regulation of mitochondrial fission | GO:0090141 | 2 | 0.165 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.163 | |
| chromosome movement towards spindle pole | GO:0051305 | 3 | 0.162 | |
| regulation of actin polymerization or depolymerization | GO:0008064 | 45 | 0.161 | |
| positive regulation of rho gtpase activity | GO:0032321 | 41 | 0.160 | |
| keratinization | GO:0031424 | 9 | 0.160 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.159 | |
| negative regulation of protein dephosphorylation | GO:0035308 | 2 | 0.158 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.156 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.155 | |
| regulation of protein complex disassembly | GO:0043244 | 28 | 0.155 | |
| cell fate specification | GO:0001708 | 72 | 0.154 | |
| keratinocyte differentiation | GO:0030216 | 48 | 0.154 | |
| oogenesis | GO:0048477 | 56 | 0.154 | |
| physiological muscle hypertrophy | GO:0003298 | 3 | 0.153 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.152 | |
| regulation of secretion | GO:0051046 | 274 | 0.150 | Human |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.149 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.148 | |
| atp catabolic process | GO:0006200 | 55 | 0.148 | |
| hippocampus development | GO:0021766 | 52 | 0.147 | |
| positive regulation of growth | GO:0045927 | 104 | 0.146 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.145 | |
| regulation of cell growth | GO:0001558 | 91 | 0.145 | |
| cell growth | GO:0016049 | 130 | 0.143 | Worm |
| vesicle organization | GO:0016050 | 60 | 0.143 | |
| learning or memory | GO:0007611 | 148 | 0.143 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.141 | Human |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.137 | Human |
| necroptotic process | GO:0070266 | 21 | 0.137 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.137 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.133 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.132 | |
| synaptic vesicle localization | GO:0097479 | 59 | 0.132 | |
| negative regulation of cell growth involved in cardiac muscle cell development | GO:0061052 | 2 | 0.132 | |
| membrane invagination | GO:0010324 | 17 | 0.131 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.131 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.131 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.131 | Human |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.131 | |
| regulation of protein localization | GO:0032880 | 231 | 0.130 | Human |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.130 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.130 | |
| regulation of cell growth involved in cardiac muscle cell development | GO:0061050 | 3 | 0.129 | |
| filopodium assembly | GO:0046847 | 19 | 0.128 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.126 | |
| substantia nigra development | GO:0021762 | 2 | 0.126 | |
| protein targeting to vacuole | GO:0006623 | 3 | 0.126 | |
| inositol phosphate mediated signaling | GO:0048016 | 13 | 0.125 | |
| multicellular organismal water homeostasis | GO:0050891 | 23 | 0.125 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.124 | |
| protein secretion | GO:0009306 | 111 | 0.124 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.123 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.123 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.123 | |
| protein stabilization | GO:0050821 | 25 | 0.122 | |
| positive regulation of ras protein signal transduction | GO:0046579 | 13 | 0.122 | |
| mitotic spindle checkpoint | GO:0071174 | 9 | 0.122 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.121 | Human |
| limbic system development | GO:0021761 | 72 | 0.121 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.121 | |
| phagocytosis | GO:0006909 | 66 | 0.119 | |
| physiological cardiac muscle hypertrophy | GO:0003301 | 3 | 0.119 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.119 | |
| positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | GO:1901030 | 6 | 0.118 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.118 | Human |
| regulation of cellular component size | GO:0032535 | 121 | 0.117 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.116 | |
| olfactory learning | GO:0008355 | 2 | 0.115 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.113 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.111 | |
| regulation of dephosphorylation | GO:0035303 | 18 | 0.110 | |
| establishment of synaptic vesicle localization | GO:0097480 | 57 | 0.109 | |
| macromolecular complex disassembly | GO:0032984 | 43 | 0.108 | |
| post embryonic hemopoiesis | GO:0035166 | 4 | 0.107 | |
| regulation of protein binding | GO:0043393 | 60 | 0.106 | Human |
| negative regulation of protein modification by small protein conjugation or removal | GO:1903321 | 20 | 0.106 | |
| female gamete generation | GO:0007292 | 74 | 0.105 | |
| regulation of protein depolymerization | GO:1901879 | 26 | 0.105 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.105 | |
| regulation of microtubule cytoskeleton organization | GO:0070507 | 37 | 0.104 | Fly |
| muscle contraction | GO:0006936 | 101 | 0.104 | |
| mitochondrion localization | GO:0051646 | 9 | 0.103 | Human Fly |
| mitotic cell cycle embryonic | GO:0045448 | 5 | 0.103 | |
| regulation of release of cytochrome c from mitochondria | GO:0090199 | 11 | 0.103 | |
| fertilization | GO:0009566 | 127 | 0.103 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.101 | Human |
| epithelial cell proliferation | GO:0050673 | 174 | 0.100 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.099 | |
| regulation of neuronal synaptic plasticity | GO:0048168 | 30 | 0.099 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.098 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.098 | Human |
| maintenance of location | GO:0051235 | 89 | 0.098 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.097 | |
| oocyte development | GO:0048599 | 33 | 0.097 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.097 | |
| nuclear dna replication | GO:0033260 | 3 | 0.096 | |
| dna replication | GO:0006260 | 52 | 0.096 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.095 | |
| heart morphogenesis | GO:0003007 | 178 | 0.095 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.094 | |
| amine metabolic process | GO:0009308 | 45 | 0.094 | |
| striated muscle contraction | GO:0006941 | 45 | 0.094 | |
| cerebral cortex development | GO:0021987 | 86 | 0.094 | |
| regulation of keratinocyte proliferation | GO:0010837 | 15 | 0.094 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.093 | |
| nuclear division | GO:0000280 | 158 | 0.093 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.093 | |
| regulation of cell migration | GO:0030334 | 219 | 0.092 | |
| muscle tissue development | GO:0060537 | 308 | 0.091 | |
| establishment of skin barrier | GO:0061436 | 14 | 0.091 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.091 | Human |
| cell growth involved in cardiac muscle cell development | GO:0061049 | 3 | 0.089 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.088 | |
| regulation of epidermal cell differentiation | GO:0045604 | 21 | 0.088 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.086 | |
| oocyte differentiation | GO:0009994 | 35 | 0.086 | |
| negative regulation of protein depolymerization | GO:1901880 | 21 | 0.086 | |
| keratinocyte proliferation | GO:0043616 | 21 | 0.085 | |
| positive regulation of stress activated mapk cascade | GO:0032874 | 48 | 0.085 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.085 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.085 | Human |
| second messenger mediated signaling | GO:0019932 | 73 | 0.085 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.085 | Human |
| jnk cascade | GO:0007254 | 72 | 0.084 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.084 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.083 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.082 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.082 | |
| regulation of mitosis | GO:0007088 | 29 | 0.082 | |
| negative regulation of mitosis | GO:0045839 | 10 | 0.081 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.081 | Human |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.081 | |
| germ cell development | GO:0007281 | 185 | 0.080 | |
| endomembrane system organization | GO:0010256 | 147 | 0.079 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.079 | |
| dna metabolic process | GO:0006259 | 303 | 0.079 | |
| regulation of actin filament depolymerization | GO:0030834 | 13 | 0.079 | |
| water homeostasis | GO:0030104 | 27 | 0.078 | |
| cation transport | GO:0006812 | 399 | 0.076 | |
| negative regulation of dendrite development | GO:2000171 | 9 | 0.076 | |
| pallium development | GO:0021543 | 120 | 0.076 | |
| regulation of epidermis development | GO:0045682 | 33 | 0.075 | |
| positive regulation of cell growth | GO:0030307 | 33 | 0.075 | |
| regulation of water loss via skin | GO:0033561 | 16 | 0.074 | |
| syncytium formation | GO:0006949 | 43 | 0.074 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.074 | |
| multicellular organismal reproductive behavior | GO:0033057 | 23 | 0.074 | |
| organic anion transport | GO:0015711 | 137 | 0.072 | |
| negative regulation of cytoskeleton organization | GO:0051494 | 36 | 0.072 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.072 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.071 | Human |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.071 | |
| protein oligomerization | GO:0051259 | 67 | 0.071 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.070 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.069 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.069 | |
| cell junction assembly | GO:0034329 | 52 | 0.069 | |
| positive regulation of epidermal cell differentiation | GO:0045606 | 6 | 0.069 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.068 | |
| negative regulation of nuclear division | GO:0051784 | 19 | 0.068 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.067 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.067 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.067 | Human |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.067 | |
| protein localization to mitochondrion | GO:0070585 | 15 | 0.066 | Human |
| epidermis development | GO:0008544 | 187 | 0.066 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.066 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.066 | |
| protein folding | GO:0006457 | 28 | 0.066 | |
| exit from mitosis | GO:0010458 | 3 | 0.065 | |
| organic acid transport | GO:0015849 | 101 | 0.065 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.065 | |
| regulation of defense response | GO:0031347 | 233 | 0.064 | |
| neutrophil mediated immunity | GO:0002446 | 19 | 0.064 | |
| regulation of proteasomal ubiquitin dependent protein catabolic process | GO:0032434 | 40 | 0.063 | |
| cell fate commitment | GO:0045165 | 210 | 0.063 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.062 | |
| muscle system process | GO:0003012 | 141 | 0.062 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.062 | |
| positive regulation of fibroblast migration | GO:0010763 | 5 | 0.062 | |
| regulation of microtubule based process | GO:0032886 | 52 | 0.062 | Fly |
| nuclear migration | GO:0007097 | 6 | 0.061 | |
| neural tube formation | GO:0001841 | 108 | 0.061 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.060 | Human |
| cell maturation | GO:0048469 | 127 | 0.060 | Human |
| chemotaxis | GO:0006935 | 247 | 0.060 | Worm |
| fatty acid metabolic process | GO:0006631 | 121 | 0.060 | |
| nuclear export | GO:0051168 | 34 | 0.059 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.059 | Mouse |
| protein catabolic process | GO:0030163 | 221 | 0.059 | |
| negative regulation of protein ubiquitination | GO:0031397 | 19 | 0.059 | |
| establishment of mitochondrion localization | GO:0051654 | 4 | 0.058 | |
| synapse organization | GO:0050808 | 125 | 0.058 | Human Fly |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.058 | |
| circulatory system process | GO:0003013 | 197 | 0.058 | |
| dna integrity checkpoint | GO:0031570 | 28 | 0.058 | |
| cellular protein complex disassembly | GO:0043624 | 36 | 0.058 | |
| exocyst localization | GO:0051601 | 2 | 0.057 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.056 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.056 | |
| positive regulation of jnk cascade | GO:0046330 | 46 | 0.056 | |
| sensory perception | GO:0007600 | 245 | 0.055 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.055 | Human |
| adherens junction assembly | GO:0034333 | 22 | 0.055 | |
| dna damage checkpoint | GO:0000077 | 26 | 0.055 | |
| positive regulation of substrate adhesion dependent cell spreading | GO:1900026 | 8 | 0.055 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.055 | |
| exocytosis | GO:0006887 | 121 | 0.054 | Human |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.054 | |
| regulated secretory pathway | GO:0045055 | 32 | 0.054 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.054 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.054 | Human |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.054 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.054 | Human Mouse |
| mitotic cell cycle | GO:0000278 | 195 | 0.054 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.053 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.053 | Human |
| multi multicellular organism process | GO:0044706 | 109 | 0.053 | |
| regulation of adrenergic receptor signaling pathway | GO:0071877 | 4 | 0.053 | |
| fibroblast migration | GO:0010761 | 21 | 0.052 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.052 | |
| defense response to bacterium | GO:0042742 | 119 | 0.052 | |
| genetic imprinting | GO:0071514 | 27 | 0.052 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.052 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.052 | |
| sulfur compound biosynthetic process | GO:0044272 | 37 | 0.052 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.052 | |
| canonical wnt signaling pathway involved in heart development | GO:0061316 | 3 | 0.051 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.051 | |
| establishment of mitotic spindle orientation | GO:0000132 | 12 | 0.051 | |
| adult behavior | GO:0030534 | 135 | 0.051 | |
| platelet derived growth factor receptor signaling pathway | GO:0048008 | 32 | 0.051 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.051 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.050 | Human |
| muscle adaptation | GO:0043500 | 39 | 0.050 | |
| plasma membrane organization | GO:0007009 | 90 | 0.050 | |
| multi organism reproductive behavior | GO:0044705 | 29 | 0.049 | |
| negative regulation of protein complex assembly | GO:0031333 | 25 | 0.049 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.049 | Human |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.049 | |
| positive regulation of lamellipodium assembly | GO:0010592 | 2 | 0.049 | |
| asymmetric cell division | GO:0008356 | 8 | 0.048 | |
| axonogenesis | GO:0007409 | 274 | 0.048 | Worm |
| positive regulation of cytoskeleton organization | GO:0051495 | 49 | 0.048 | |
| calcineurin nfat signaling cascade | GO:0033173 | 8 | 0.048 | |
| cell fate determination | GO:0001709 | 32 | 0.048 | |
| regulation of lamellipodium organization | GO:1902743 | 5 | 0.048 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.047 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.047 | |
| dendrite development | GO:0016358 | 115 | 0.047 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.047 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.047 | |
| necrotic cell death | GO:0070265 | 30 | 0.047 | |
| blood circulation | GO:0008015 | 195 | 0.047 | |
| actin filament based movement | GO:0030048 | 23 | 0.047 | |
| arp2 3 complex mediated actin nucleation | GO:0034314 | 3 | 0.046 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.046 | Human Mouse |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 56 | 0.046 | |
| positive regulation of peptidyl serine phosphorylation | GO:0033138 | 25 | 0.046 | |
| myeloid leukocyte mediated immunity | GO:0002444 | 42 | 0.046 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.045 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.045 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.045 | Human |
| protein complex disassembly | GO:0043241 | 40 | 0.045 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.045 | |
| cellular response to peptide | GO:1901653 | 92 | 0.045 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.045 | Human |
| regulation of microtubule polymerization or depolymerization | GO:0031110 | 20 | 0.044 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.044 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.044 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.044 | |
| regulation of cell motility | GO:2000145 | 236 | 0.044 | |
| innate immune response | GO:0045087 | 157 | 0.044 | |
| multi organism behavior | GO:0051705 | 62 | 0.044 | |
| regulation of binding | GO:0051098 | 111 | 0.044 | Human |
| synapse assembly | GO:0007416 | 56 | 0.043 | |
| neural nucleus development | GO:0048857 | 22 | 0.043 | |
| regulation of protein dephosphorylation | GO:0035304 | 4 | 0.043 | |
| positive regulation of actin filament polymerization | GO:0030838 | 26 | 0.043 | |
| negative regulation of nfat protein import into nucleus | GO:0051534 | 3 | 0.043 | |